• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《化脓性汗腺炎患者的住院管理:德尔菲共识研究》

Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study.

机构信息

McKenzie Needham and Drs. Pichardo and Strowd are from the Wake Forest University School of Medicine, Winston-Salem, North Carolina. Drs. Pichardo and Strowd also are from the Department of Dermatology, Atrium Health Wake Forest Baptist, Winston-Salem. Dr. Alavi is from the Department of Dermatology, Mayo Clinic, Rochester, Minnesota. Drs. Chang and Fox are from the Department of Dermatology, School of Medicine, University of California San Francisco. Dr. Daveluy is from the School of Medicine, Wayne State University, Detroit, Michigan. Dr. DeNiro is from the Division of Dermatology, Department of Medicine, University of Washington, Seattle. Dr. Dewan is from Vanderbilt University Medical Center, Nashville, Tennessee. Drs. Eshaq and Manusco are from the Department of Dermatology, University of Michigan Medical School, Ann Arbor. Dr. Hsiao is from the Department of Dermatology, University of Southern California, Los Angeles. Dr. Kaffenberger is from the Department of Dermatology, Ohio State University, Columbus. Dr. Kirby is from the Department of Dermatology, Penn State Milton S. Hershey Medical Center, Pennsylvania, and Incyte Corporation, Wilmington, Delaware. Drs. Kroshinsky, Mostaghimi, and Porter are from the Department of Dermatology, Harvard Medical School, Boston, Massachusetts. Drs. Kroshinsky and Mostaghimi also are from the Department of Dermatology, Brigham & Women's Hospital, Boston. Dr. Porter also is from the Department of Dermatology, Beth Israel Deaconess Medical Center, Boston. Dr. Ortega-Loayza is from the Department of Dermatology, Oregon Health & Science University, Portland. Dr. Micheletti is from the Departments of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia. Dr. Nelson is from the Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Dr. Pasieka is from the Department of Dermatology and Medicine, Uniformed Services University, Bethesda, Maryland. Dr. Resnik is from the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Florida. Dr. Sayed is from the Department of Dermatology, University of North Carolina at Chapel Hill. Dr. Shi is from the Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock. Dr. Shields is from the Department of Dermatology, University of Wisconsin, Madison.

出版信息

Cutis. 2024 Jun;113(6):251-254. doi: 10.12788/cutis.1027.

DOI:
10.12788/cutis.1027
PMID:39082985
Abstract

Inpatient hospitalization of individuals with hidradenitis suppurativa (HS) has increased. Inpatient services may not be familiar enough with this disease to understand how to manage severe HS and/or HS flares. It would be beneficial to the inpatient medical community to establish consensus recommendations on holistic inpatient care of patients with HS. A survey study was developed and distributed by Wake Forest University School of Medicine (Winston-Salem, North Carolina). A total of 26 dermatologists participated in the Delphi process, and the process was conducted in 2 rounds. Participants voted on proposal statements using a 9-point scale (1=very inappropriate; 9=very appropriate). Statements were developed using current published guidelines for management of HS and supportive care guidelines for other severe inpatient dermatologic diseases. A total of 50 statements were reviewed and voted on between the 2 rounds. Consensus was determined using the RAND/UCLA Appropriateness Method. Twenty-six dermatologists completed the first-round survey, and 24 completed the second-round survey. The 40 consensus recommendations generated through these surveys can serve as a resource for providers caring for inpatients with HS.

摘要

患有化脓性汗腺炎(HS)的个体住院治疗的人数有所增加。住院服务可能对这种疾病不够熟悉,无法了解如何治疗严重的 HS 和/或 HS 发作。为住院医疗界制定关于 HS 患者整体住院护理的共识建议将是有益的。这项调查研究由维克森林大学医学院(北卡罗来纳州温斯顿-塞勒姆)开发和分发。共有 26 名皮肤科医生参与了德尔菲法过程,该过程分两轮进行。参与者使用 9 分制(1=非常不合适;9=非常合适)对提案进行投票。这些陈述是使用当前发表的 HS 管理指南和其他严重住院皮肤科疾病的支持性护理指南制定的。在两轮之间共审查和投票了 50 条陈述。使用 RAND/UCLA 适宜性方法确定了共识。26 名皮肤科医生完成了第一轮调查,24 名完成了第二轮调查。通过这些调查产生的 40 条共识建议可以为照顾 HS 住院患者的医务人员提供资源。

相似文献

1
Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study.《化脓性汗腺炎患者的住院管理:德尔菲共识研究》
Cutis. 2024 Jun;113(6):251-254. doi: 10.12788/cutis.1027.
2
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement.用于临床评估化脓性汗腺炎治疗反应的结局指标:一项 HiSTORIC 共识声明。
JAMA Dermatol. 2023 Nov 1;159(11):1258-1266. doi: 10.1001/jamadermatol.2023.3282.
3
Expert consensus on unmet needs, referral criteria and treatment goals for hidradenitis suppurativa in Saudi Arabia.沙特阿拉伯关于化脓性汗腺炎未满足需求、转诊标准和治疗目标的专家共识。
J Dermatolog Treat. 2024 Dec;35(1):2353693. doi: 10.1080/09546634.2024.2353693. Epub 2024 Jun 11.
4
Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary.全球化脓性汗腺炎形态学定义的协调一致,以提出一个术语表。
JAMA Dermatol. 2021 Apr 1;157(4):449-455. doi: 10.1001/jamadermatol.2020.5467.
5
Infectious Disease Screening prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa Foundation.化脓性汗腺炎系统免疫调节治疗前的感染性疾病筛查:亚太化脓性汗腺炎基金会共识指南。
Dermatology. 2024;240(3):494-506. doi: 10.1159/000534575. Epub 2023 Nov 14.
6
Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document.《化脓性汗腺炎患者管理指南:共识文件》。
J Cutan Med Surg. 2017 Nov/Dec;21(6):513-524. doi: 10.1177/1203475417716117. Epub 2017 Jun 22.
7
Expert consensus on priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa: a Delphi consensus study.专家共识:饮食和生活方式因素在化脓性汗腺炎中的优先研究空白:德尔菲共识研究。
Arch Dermatol Res. 2023 Sep;315(7):2129-2136. doi: 10.1007/s00403-023-02610-9. Epub 2023 Mar 23.
8
Global consensus process to establish a core dataset for hidradenitis suppurativa registries.建立化脓性汗腺炎注册核心数据集的全球共识过程。
Br J Dermatol. 2024 Mar 15;190(4):510-518. doi: 10.1093/bjd/ljad454.
9
Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes.用于开发化脓性汗腺炎试验结局核心领域集的方案。
BMJ Open. 2017 Feb 20;7(2):e014733. doi: 10.1136/bmjopen-2016-014733.
10
Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts.化脓性汗腺炎患者新冠疫苗接种指南:专家修改后的德尔菲共识
Skin Appendage Disord. 2022 Jul;8(4):287-290. doi: 10.1159/000521268. Epub 2022 Jan 10.